A biological clock synchronizes animal behaviour and physiology with Earth's 24-hour rotation. Drugs targeting the clock's 'gears' show promise for treating obesity and other metabolic disorders. See Article p.62 & Letter p.123
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Janszky, I. et al. Sleep Med. 13, 237–242 (2012).
Solt, L. A. et al. Nature 485, 62–68 (2012).
Cho, H. et al. Nature 485, 123–127 (2012).
Balsalobre, A., Damiola, F. & Schibler, U. Cell 93, 929–937 (1998).
Hughes, M. E. et al. PLoS Genet. 5, e1000442 (2009).
Lazar, M. A., Hodin, R. A., Darling, D. S. & Chin, W. W. Mol. Cell. Biol. 9, 1128–1136 (1989).
Preitner, N. et al. Cell 110, 251–260 (2002).
Raspé, E. et al. J. Lipid Res. 43, 2172–2179 (2002).
Le Martelot, G. et al. PLoS Biol. 7, e1000181 (2009).
Wang, J. & Lazar, M. A. Mol. Cell. Biol. 28, 2213–2220 (2008).
Raghuram, S. et al. Nature Struct. Mol. Biol. 14, 1207–1213 (2007).
Yin, L. et al. Science 318, 1786–1789 (2007).
Wu, N. et al. Genes Dev. 23, 2201–2209 (2009).
Liu, A. C. et al. PLoS Genet. 4, e1000023 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Joseph Bass provides consulting and speakers bureau services to Merck and to Gerhson Lehrman Group. He has received research funding from Amylin Pharmaceuticals, Eli Lilly and Takeda Pharmaceuticals. He is a member of the advisory board and a stockholder of Reset Therapeutics. Neither of these companies is mentioned, or specifically alluded to, in this article.
Rights and permissions
About this article
Cite this article
Bass, J. Time in a bottle. Nature 485, 45–46 (2012). https://doi.org/10.1038/485045a
Published:
Issue Date:
DOI: https://doi.org/10.1038/485045a